meta
|
evidence
oncology
Living systematic review and meta-analysis
metastatic/advanced - breast cancer (mBC)
1
cervical cancer (CC)
classical Hodgkin lymphoma (cHL)
antibody–drug conjugate
tisotumab vedotin-tftv
immune chekpoint inhibitors
anti-PD-(L)1
atezolizumab based treatment
atezolizumab alone
durvalumab based treatment
durvalumab alone
pembrolizumab based treatment
pembrolizumab alone
pembrolizumab plus SoC
no study with result for this clinical condition